A single vial can service several doses or procedures, reducing procurement burden and storage space requirements
To address these knowledge gaps, future studies should focus on several key directions
Auerdem geben wir Informationen zu Ihrer Verwendung unserer Website an unsere Partner fr soziale Medien, Werbung und Analysen weiter
Sean Scanlon, the Connecticut comptroller, said that not covering GLP-1s is shortsighted, bad policy. The state health plan, which takes care of teachers and other state employees, has been covering the drugs for weight loss since 2023
The most common pitfall Katz sees is relying solely on appetite suppression and not establishing healthy habits that can help keep the weight off for the long-term
This article explores the current status of oral GLP-1 drugs, what they mean for diabetes care, and how they may change the treatment landscape